YOKNEAM, Israel, Aug. 1, 2024/ PRNewswire/-- InMode Ltd., a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...

Expects Q1 Revenue Between $80.0M-$80.1M, Pro Forma Revenue (including new platform pre-orders) Between $95.7M- $95.8M, Decreases FY 2024 Guidance to $485M-$495M Conference call to be held on Thursday ...

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International ...

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro ...

YOKNEAM, Israel, July 10, 2025 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

Therefore, we continue to provide pro forma results, which add to the non-GAAP results, the pre-order sales and related expenses. We believe that the pro forma results better reflect our business ...

Logo: https://mma.prnewswire.com/media/1064477/4839231/InMode_Logo.jpg ...

Good morning and welcome to the InMode first-quarter 2024 earnings results conference call. [Operator instructions] Please note this event is being recorded. I would now like to hand the conference ...